Progress in etiology, prevention and treatment of vascular cognitive impairment without dementia

LIAO Weilong; JIANG Wenfei; SUN Chuanhe; GAO Penglin; PAN Weidong

doi:10.12022/jnnr.2017-0015

PDF(1606 KB)

Journal of Neurology and Neurorehabilitation ›› 2017, Vol. 13 ›› Issue (2) : 85-90. DOI: 10.12022/jnnr.2017-0015

Review

Progress in etiology, prevention and treatment of vascular cognitive impairment without dementia

LIAO Weilong, JIANG Wenfei, SUN Chuanhe, GAO Penglin, PAN Weidong

Author information +

History +

Abstract

With the aging of the population, vascular cognitive impairment without dementia has become a disease that affects the quality of life and gives the burdens to social economy and emotion. Vascular cognitive impairment without dementia is an early stage of vascular cognitive impairment. Early intervention can delay or even reverse the decline of cognitive function, improve the quality of life, and save medical resources. From the perspective of modern medicine and traditional Chinese medicine, this paper addresses the etiology and pathogenesis of vascular cognitive impairment without dementia, and at the same time reviews the advances in prevention and treatment of this disease, in order to provide theoretical basis for the clinical practice and scientific research.

Key words

Vascular cognitive impairment without dementia / Epidemiology / Pathogeny / Prevention / Treatment

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LIAO Weilong, JIANG Wenfei, SUN Chuanhe, GAO Penglin, PAN Weidong. Progress in etiology, prevention and treatment of vascular cognitive impairment without dementia[J]. Journal of Neurology and Neurorehabilitation. 2017, 13(2): 85-90 https://doi.org/10.12022/jnnr.2017-0015

References

[1] Hachinski VC, BowlerJV. Vascular dementia[J]. Neurology, 1993, 43(10):2159-2160.
[2] Rockwood K, Black SE, Song X, et al. Clinical and radiographic subtype of vascular cognitive impairment in a clinic-based cohort study[J]. J Neural Sci, 2006, 240(1-2):7-14.
[3] Stephan BC, Matthews FE, Khaw KT, et al. Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)[J]. Alzheimers Res Ther, 2009, 1(1):4.
[4] Solfrizzi V, Scafato E, Frisardi V, et al. Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging[J]. Alzheimers Dement, 2013, 9(2):113-122.
[5] Thal DR, Grinberg LT, Attems J. Vascular dementia:different forms of vessel disorders contribute to the development of dementia in the elderly brain[J]. Exp Gerontol, 2012, 47(11):816-824.
[6] Rockwood K, Wentzel C, Hachinski V, et al. Prevalence and outcomes of vascular cognitive impairment[J]. Neurology, 2000, 54(2):447-451.
[7] Wentzel C, Rockwood K, MacKnight C, et al. Progression of impairment in patients with vascular cognitive impairment without dementia[J]. Neurology, 2001, 57(4):714-716.
[8] Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study[J]. Neuroepidemiology, 2007, 29(1-2):125-132.
[9] Plassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States[J]. Ann Intern Med, 2008, 148(6):427-434.
[10] Jia J, Zhou A, Wei C, et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese[J]. Alzheimers Dement, 2014, 10(4):439-447.
[11] Wang F, Zou ZR, Yuan D, et al. Correlation between serum S100β protein levels and cognitive dysfunction in patients with cerebral small vessel disease: a case-control study[J]. Biosci Rep, 2017, 37(2). pii: BSR20160446. doi: 10.1042/BSR20160446.
[12] 张春燕, 田玉玲, 李　阳, 等．血管性认知障碍非痴呆患者的神经心理学特征及相关影响因素[J]. 中华脑科疾病与康复杂志, 2015, 5(6):401-406.
[13] Verhaaren BF, Vernooij MW, de Boer R, et al. High blood pressure and cerebral white matter lesion progression in the general population[J]. Hypertension, 2013, 61(6):1354-1359.
[14] 程　哲, 王　玥, 赵　丽, 等. 不同程度血管性认知功能障碍患者血脂水平变化及意义[J]. 山东医药, 2015, 55(23):42-43.
[15] Braunwald E, Peter ZL, Bonow R. Heart Disease[M]. 7th ed. Philadelphia: W.B. Saunders Compang, 2004:1023-1024．
[16] 吴春芳. 血脂水平与非痴呆型血管性认知功能损害关系的研究[J]. 数理医药学杂志, 2016, 29(6):851-852.
[17] Mogi M, Horiuchi M. Neurovascular coupling in cognitive impairment associated with diabetes mellitus[J]. Circ J, 2011, 75(5):1042-1048.
[18] Umegaki H. Neurodegeneration in diabetes mellitus[J]. Adv Exp Med Biol, 2012, 724:258-265.
[19] 李　伟, 赵　翠, 王　淼, 等. 糖调节受损与老年非痴呆型血管性认知功能障碍的相关性观察[J]. 临床军医杂志, 2015, 43(7):696-699.
[20] Jiang B, Chen Y, Yao G, et al. Effects of differences in serum total homocysteine, folate, and vitamin B12 on cognitive impairment in stroke patients[J]. BMC Neurol, 2014, 14:217.
[21] 尹　楠. 非痴呆型血管性认知功能障碍患者危险因素的初步研究[J]. 河北医药, 2014, 36(24):3781-3782.
[22] Roman GC, Sachdev P, Royall DR, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia[J]. J Neurol Sci, 2004, 226(1-2):81-87.
[23] 张春燕, 田玉玲, 李　阳, 等. 血管性认知障碍非痴呆患者的神经心理学特征及相关影响因素[J]. 中华脑科疾病与康复杂志, 2015, 5(6):401-406.
[24] 熊　芳. 脑卒中高危人群非痴呆性血管性认知功能障碍危险因素分析[J]. 现代仪器与医疗, 2016, 22(1):118-120.
[25] Saczynski JS, Sigurdsson S, Jonsdottir MK, et al. Cerebral infarcts and cognitive performance:importance of location and number of infarcts[J]. Stroke, 2009, 40(3):677-682.
[26] 邹正寿, 王东玉. 非痴呆型血管性认知障碍与脑梗死部位、TCD相关性的临床研究[J]. 中国现代医学杂志, 2014, 24(12):79-82.
[27] 富　蓉. 不同部位脑出血对患者认知功能的影响[J]. 中国实用医刊, 2013, 40(19):31-32.
[28] 赵少荣, 张晓虹. 非痴呆型血管性认知障碍的临床分析[J]. 中国实用神经疾病杂志, 2011, 14(21):55-56.
[29] Sun YW, Qin LD, Zhou Y, et al. Abnormal functional connectivity in patients with vascular cognitive impairment, no dementia: A resting-state functional magnetic resonance imaging study[J]. Behav Brain Res, 2011, 223(2):388-394.
[30] 潘丽雅, 翁保慧, 邓　珊. 非痴呆型血管认知功能障碍危险因素分析[J]. 内科, 2014, 9(4):375-377.
[31] 杨志新. 卒中后轻度认知功能障碍与中医证候的相关性研究[J]. 神经病学与神经康复学杂志, 2010, 7(2):112-113.
[32] 刘　屹, 史红星, 李青丽, 等. 从痰瘀论治非痴呆型血管性认知功能障碍[J]. 河南中医, 2015, 35(11):2589-2590.
[33] Sharp SI, Aarsland D, Day S, et al. Hypertension is a potential risk factor for vascular dementia: systematic review[J]. Int J Geriatr Psychiatry, 2011, 26(7):661-669.
[34] Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)[J]. Atherosclerosis, 2016, 253:281-344.
[35] 吴金辉. 盐酸多奈哌齐联合养血清脑颗粒治疗非痴呆型血管性认知障碍临床研究[J]. 中国实用神经疾病杂志, 2016, 19(8):122-123.
[36] 江　波, 孟晓落, 舒刚明, 等. 非痴呆型血管性认知功能障碍患者神经心理学特点及石杉碱甲的临床疗效观察[J]. 中国临床神经科学, 2009, 17(5):510-514.
[37] 徐光青, 兰　月, 丁明晖, 等. 美金刚治疗脑卒中后认知障碍的随机、安慰剂对照研究[J]. 中国新药与临床杂志, 2010, 29(5):358-361.
[38] 杜远敏. 尼莫地平治疗血管性非痴呆认知障碍的疗效观察[J]. 中国药师, 2014, 17(12):2120-2122.
[39] Jia JP, Wei CB, Liang JH, et al. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial[J]. Alzheimers Dement, 2016, 12(2):89-99.
[40] Yang BF, Zeng XH, Liu Y, et al. Effect of acupuncture treatment on vascular cognitive impairment without dementia: study protocol for a randomized controlled trial[J]. Trials, 2014, 15:442.
[41] Wang LP, Zhang XY, Liu N, et al. Comparison of integrated traditional Chinese and western medicine therapy on vascular cognitive impairment with no dementia[J]. Genet Mol Res, 2015, 14(2):4896-4902.
[42] 任志欣, 朱敬云. 针刺与醒脑静并用对改善轻度非痴呆血管性认知障碍患者认知功能的效果分析[J]. 中国实用神经疾病杂志, 2016, 19(8):109-110.
[43] Jorge RE, Acion L, Moser D, et al. Escitalopram and enhancement of cognitive recovery following stroke[J]. Arch Gen Psychiatry, 2010, 67(2):187-196.